S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 28 of 28

Issue Date	Title / Author(s) / Citation	File
2018-05	18F-FDG PET and histopathologic findings in a patient with severe fever with thrombocytopenia syndrome Kang, Chang Kyung; Choi, Su Jin; Koh, Jiwon; Jeon, Yoon Kyung; Kim, Ki Hyun; Chung, Junho; Choe, Pyoeng Gyun; Kim, Nam-Joong; Park, Wan Beom; Oh, Myoung Don Ticks and Tick-borne Diseases, Vol.9 No.4, pp.972-975	DOI
2019-03	A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors Fukamachi, Hiroshi; Kim, Seon-Kyu; Koh, Jiwon; Lee, Hye Seung; Sasaki, Yasushi; Yamashita, Kentaro; Nishikawaji, Taketo; Shimada, Shu; Akiyama, Yoshimitsu; Byeon, Sun-ju; Bae, Dong-Hyuck; Okuno, Keisuke; Nakagawa, Masatoshi; Tanioka, Toshiro; Inokuchi, Mikito; Kawachi, Hiroshi; Tsuchiya, Kiichiro; Kojima, Kazuyuki; Tokino, Takashi; Eishi, Yoshinobu; Kim, Yong Sung; Kim, Woo Ho; Yuasa, Yasuhito; Tanaka, Shinji Journal of Experimental & Clinical Cancer Research. 2019 Mar 12;38(1):127	view file DOI
2019-12	Trastuzumab specific epitope evaluation as a predictive and prognostic biomarker in gastric cancer patients Koh, Jiwon; Nam, Soo Kyung; Lee, Youn Woo; Kim, Jin Won; Lee, Keun-Wook; Ock, Chan-Young; Oh, Do-Youn; Ahn, Sang-Hoon; Kim, Hyung-Ho; Kang, Keon-Wook; Kim, Woo Ho; Lee, Ho-Young; Lee, Hye Seung Biomolecules, Vol.9 No.12, p. 782	DOI
2020-06	Discovery of novel recurrent mutations and clinically meaningful subgroups in nodal marginal zone lymphoma Koh, Jiwon; Jang, Insoon; Choi, Seongmin; Kim, Sehui; Jang, Ingeon; Ahn, Hyun Kyung; Lee, Cheol; Paik, Jin Ho; Kim, Chul Woo; Lim, Megan S.; Kim, Kwangsoo; Jeon, Yoon Kyung Cancers, Vol.12 No.6, pp.1669-17	DOI
2020-11	Immunophenotypic landscape and prognosis of diffuse large B-cell lymphoma with MYC/BCL2 double expression: An analysis of a prospectively immunoprofiled cohort Han, Bogyeong; Kim, Sehui; Koh, Jiwon; Yim, Jeemin; Lee, Cheol; Heo, Dae Seog; Kim, Tae Min; Paik, Jin Ho; Jeon, Yoon Kyung Cancers, Vol.12 No.11, pp.3305-15	DOI
2021-08	A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas Kim, Miso; Lee, Jeong-Ok; Koh, Jiwon; Kim, Tae Min; Lee, Ji Yun; Jeon, Yoon Kyung; Keam, Bhumsuk; Kim, Dong Wan; Lee, Jong Seok; Heo, Dae Seog Haematologica, Vol.106 No.8, pp.2277-2280	DOI
2021-10	Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations Koh, Jiwon; Jang, Insoon; Mun, Seungchan; Lee, Cheol; Cha, Hee Jeong; Oh, Young Ha; Kim, Jin-Man; Han, Jae Ho; Paik, Jin Ho; Cho, Junhun; Ko, Young Hyeh; Park, Chan-Sik; Go, Heounjeong; Huh, Jooryung; Kim, Kwangsoo; Jeon, Yoon Kyung Blood Advances, Vol.5 No.20, pp.3919-3930	DOI
2021-12	Prognostic significance of natural killer cell-associated markers in gastric cancer: quantitative analysis using multiplex immunohistochemistry Na, Hee Y.; Park, Yujun; Nam, Soo K.; Koh, Jiwon; Kwak, Yoonjin; Ahn, Sang-Hoon; Park, Do J.; Kim, Hyung-Ho; Lee, Kyu S.; Lee, Hye S. Journal of Translational Medicine. 2021 Dec 24;19(1):529	view file link
2022-01	Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma Lee, Ki Rim; Koh, Jiwon; Jeon, Yoon Kyung; Kwon, Hyun Jung; Lee, Jeong-Ok; Paik, Jin Ho Journal of Pathology and Translational Medicine, Vol.56 No.1, pp.32-39	DOI
2022-04	Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System An Analysis of 11 Cases Using Targeted Gene Sequencing Yim, Jeemin; Koh, Jiwon; Kim, Sehui; Song, Seung Geun; Bae, Jeong Mo; Yun, Hongseok; Sung, Ji-Youn; Kim, Tae Min; Park, Sung-Hye; Jeon, Yoon Kyung American Journal of Surgical Pathology, Vol.46 No.4, pp.486-497	DOI
2022-05	Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agent Jung, Minsun; Lee, Kyung-Min; Im, Yebin; Seok, Seung Hyeok; Chung, Hyewon; Kim, Da Young; Han, Dohyun; Lee, Cheng Hyun; Hwang, Eun Hye; Park, Soo Young; Koh, Jiwon; Kim, Bohyun; Nikas, Ilias P.; Lee, Hyebin; Hwang, Daehee; Ryu, Han Suk Molecular Oncology, Vol.16 No.9, pp.1795-1815	DOI
2022-09	Feasibility and safety of a novel 3D-printed biodegradable biliary stent in an in vivo porcine model: a preliminary study Kim, Jae Hyun; Ha, Dong-Heon; Han, Eui Soo; Choi, YoungRok; Koh, Jiwon; Joo, Ijin; Kim, Jung Hoon; Cho, Dong-Woo; Han, Joon Koo Scientific Reports, Vol.12 No.1, p. 15875	DOI
2022-10	Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features Lim, Sojung; Lim, Ka Young; Koh, Jiwon; Bae, Jeong Mo; Yun, Hongseok; Lee, Cheol; Kim, Young A.; Paik, Jin Ho; Jeon, Yoon Kyung American Journal of Surgical Pathology, Vol.46 No.10, pp.1397-1406	DOI
2023-01	Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression Paik, Jin Ho; Koh, Jiwon; Han, Bogyeong; Kim, Sehui; Lee, Ki Rim; Lee, Sejoon; Lee, Jeong-Ok; Kim, Tae Min; Kim, Wook Youn; Jeon, Yoon Kyung Human Pathology, Vol.131, pp.47-60	DOI
2023-07	Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer Park, Yeon Hee; Im, Seock-Ah; Park, Kyunghee; Wen, Ji; Lee, Kyung-Hun; Choi, Yoon-La; Lee, Won-Chul; Min, Ahrum; Bonato, Vinicius; Park, Seri; Ram, Sripad; Lee, Dae-Won; Kim, Ji-Yeon; Lee, Su Kyeong; Lee, Won-Woo; Lee, Jisook; Kim, Miso; Kim, Hyun Seon; Weinrich, Scott L.; Ryu, Han Suk; Kim, Tae Yong; Dann, Stephen; Kim, Yu-Jin; Fernandez, Diane R.; Koh, Jiwon; Wang, Shuoguo; Park, Song Yi; Deng, Shibing; Powell, Eric; Ravi, Rupesh Kanchi; Bienkowska, Jadwiga; Rejto, Paul A.; Park, Woong-Yang; Kan, Zhengyan Genome Medicine, Vol.15 No.1, p. 55	DOI
2023-07	Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer Park, Yeon Hee; Im, Seock-Ah; Park, Kyunghee; Wen, Ji; Lee, Kyung-Hun; Choi, Yoon-La; Lee, Won-Chul; Min, Ahrum; Bonato, Vinicius; Park, Seri; Ram, Sripad; Lee, Dae-Won; Kim, Ji-Yeon; Lee, Su Kyeong; Lee, Won-Woo; Lee, Jisook; Kim, Miso; Kim, Hyun Seon; Weinrich, Scott L.; Ryu, Han Suk; Kim, Tae Yong; Dann, Stephen; Kim, Yu-Jin; Fernandez, Diane R.; Koh, Jiwon; Wang, Shuoguo; Park, Song Yi; Deng, Shibing; Powell, Eric; Ravi, Rupesh K.; Bienkowska, Jadwiga; Rejto, Paul A.; Park, Woong-Yang; Kan, Zhengyan Genome Medicine, Vol.15(1):55	view file DOI
2023-10	Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single-center, retrospective, longitudinal cohort study Kim, Dong Hyun; Lim, Yoojoo; Kim, Sukjun; Ock, Chan-Young; Youk, Jeonghwan; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Kim, Hak Jae; Koh, Jiwon; Jung, Kyeong Cheon; Na, Kwon Joong; Kang, Chang Hyun; Keam, Bhumsuk Thoracic Cancer, Vol.14 No.30, pp.3001-3011	DOI
2023-11	The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer Choi, Ji Eun; Lee, Jae Seok; Jin, Min-Sun; Nikas, Ilias P.; Kim, Kwangsoo; Yang, Sunah; Park, Soo Young; Koh, Jiwon; Yang, Sohyeon; Im, Seock-Ah; Ryu, Han Suk Breast Cancer Research, Vol.25 No.1, p. 134	DOI
2023-11	The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer Choi, Ji Eun; Lee, Jae Seok; Jin, Min-Sun; Nikas, Ilias P.; Kim, Kwangsoo; Yang, Sunah; Park, Soo Young; Koh, Jiwon; Yang, Sohyeon; Im, Seock-Ah; Ryu, Han Suk Breast Cancer Research, Vol.25(1):134	view file DOI
2023-12	HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results Seo, Jeongmin; Koh, Jiwon; Lee, Dae-Won; Kim, Jinyong; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock-Ah Breast Cancer Research, Vol.25 No.1, p. 154	DOI
2023-12	HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results Seo, Jeongmin; Koh, Jiwon; Lee, Dae-Won; Kim, Jinyong; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock-Ah Breast Cancer Research, Vol.25(1):154	view file DOI
2024-06	Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study Tan, Ryan Ying Cong; Ong, Whee Sze; Lee, Kyung-Hun; Park, Seri; Iqbal, Jabed; Park, Yeon Hee; Lee, Jeong Eon; Yu, Jong Han; Lin, Ching-Hung; Lu, Yen-Shen; Ono, Makiko; Ueno, Takayuki; Naito, Yoichi; Onishi, Tatsuya; Lim, Geok-Hoon; Tan, Su-Ming; Lee, Han-Byoel; Koh, Jiwon; Han, Won Shik; Im, Seock-Ah; Tan, Veronique Kiak Mien; Phyu, Nitar; Wong, Fuh-Yong; Tan, Puay Hoon; Yap, Yoon-Sim Journal of the National Comprehensive Cancer Network : JNCCN, Vol.22 No.2D, p. e237121	DOI
2024-06	Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution Lim, Sojung; Koh, Jiwon; Bae, Jeong Mo; Yun, Hongseok; Lee, Cheol; Paik, Jin Ho; Kim, Tae Min; Jeon, Yoon Kyung Diagnostic Pathology, Vol.19 No.1, p. 86	DOI
2024-07	Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series Kang, Hyeon Gyu; Koh, Jiwon; Kim, Tae Min; Han, Doo Hee; Won, Tae-Bin; Kim, Dong-Wan; Kim, Dong-Young; Keam, Bhumsuk CANCER RESEARCH AND TREATMENT, Vol.56 No.3, pp.967-971	DOI
2024-08	The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancer Lee, Jangsoon; Kida, Kumiko; Koh, Jiwon; Liu, Huey; Manyam, Ganiraju C.; Gi, Young Jin; Rampa, Dileep R.; Multani, Asha S.; Wang, Jing; Jayachandran, Gitanjali; Lee, Dae-Won; Reuben, James M.; Sahin, Aysegul; Huo, Lei; Tripathy, Debu; Im, Seock-Ah; Ueno, Naoto T. Journal of Experimental and Clinical Cancer Research, Vol.43 No.1, p. 236	DOI
2024-10	Tracing the evolutionary history of breast cancer Koh, Jiwon; Im, Seock-Ah Nature Reviews Cancer, Vol.24 No.10, pp.653-653	DOI
2024-12	Immune marker expression and prognosis of early breast cancer expressing HER3 Lee, Dae-Won; Ryu, Han Suk; Nikas, Ilias P.; Koh, Jiwon; Kim, Tae-Yong; Kim, Hong Kyu; Lee, Han-Byoel; Moon, Hyeong-Gon; Han, Wonshik; Lee, Kyung-Hun; Im, Seock-Ah EUROPEAN JOURNAL OF CANCER, Vol.213	DOI
2025-05	Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived models Kim, Soon-Chan; Kim, Ga-Hye; Park, Jae-Hyeon; Lee, Kyung-Hun; Koh, Jiwon; Kim, Tae-Yong; Lee, Dae-Won; Kim, Yu-Jin; Kim, Seongyeong; Park, Song-Yi; Min, Ahrum; Shin, Young-Kyoung; Im, Seock-Ah; Ku, Ja-Lok BREAST CANCER RESEARCH, Vol.27 No.1	DOI